Oral drug 2-deoxy-D-glucose (2-DG), created by DRDO‘s lab Institute of Nuclear Medicine and Allied Sciences in association with Dr. Reddy’s lab, has been approved for emergency use in India by DCGI. As India is witnessing the havoc of the second wave of COVID-19 pandemic, this drug can prove to be very beneficial for the early recovery of patients. In April 2020, during the first wave of the pandemic in the country, the INMAS-DRDO scientists conducted experiments with the help of Hyderabad’s Center for Cellular and Molecular Biology (CCMB) and found that this molecule works effectively against SARS-CoV-2 virus. 2-DG will come in powder form and will be consumed by dissolving in water.
*Please create a profile first to EARN & REDEEM points
DCGI approves DRDO’s 2-DG drug for emergency use in COVID-19 treatment
We are building a board of industry expert to help us verify important news stories. If you would like to empanel yourself, please click here.